Showing posts with label PATM. Show all posts
Showing posts with label PATM. Show all posts
Saturday, April 13, 2024

Exhale The Difference: Propylene Oxide as a Game-Changer in Identifying Idiopathic Malodor Conditions

›
A new study posted on MedrXiv  sheds light on the potential of breath analysis as a powerful, non-invasive diagnostic tool for Trimethylamin...
Monday, November 13, 2023

Rare Diseases in the Era of High-Cost Drug Development

›
We are currently witnessing a remarkable era in medical innovation, marked by rapid advancements and transformative developments. Yet the me...
Saturday, August 26, 2023

Chronicles of Community-Driven Research: The Evolution of MEBO and PATM Studies

›
In the ever-evolving landscape of medical science, the untangling of medical mysteries often hinges not just on technological advancements o...
Sunday, August 20, 2023

Human Skin Gas Profiles in PATM

›
People Allergic to Me (PATM) is a perplexing condition that has left both sufferers and medical professionals searching for answers. Thousan...
Thursday, March 23, 2023

Lactobacillus, Bifidobacterium and other emerging probiotics

›
In the past few decades, Lactobacillus and Bifidobacterium genera were the main bacteria to be used as probiotics. One of the reasons for su...
Friday, July 2, 2021

Viruses and Vaccines

›
The COVID-19 Back-to-normal study was initiated in January 2021 as an effort of a tight-​knit neighborhood to help each other avoid the viru...
1 comment:
Monday, June 21, 2021

COVID-19 and vaccine reactogenicity in MEBO/PATM community

›
Infections have been shown to alter body odor and so have immunizations. So far, only nonhuman animals were able to detect the subtle change...
Wednesday, November 4, 2020

New Paper Reveals Insights into Bacteria that Live on Your Skin and in Your Gut

›
What do MEBO (metabolic body odor), PATM ("People are Allergic to ME" condition) and TMAU (trimethylaminuria) have in common - bes...
1 comment:
Saturday, November 30, 2019

Concluding the MEBO-uBiome study

›
We are very close to concluding our clinical trial  NCT03582826 ​ according to the pre-specified protocol.  Recruitment for our microbio...